For health care professionals in EUROPE excepted those practicing in France as the following pages are intended to all International health care professionals and are not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Other health care professionals should select their country in the top right corner of the website.
Please note that the following pages are exclusively reserved for health care professionals in countries with applicable health authority product registrations. To the extent this site contains information, reference guides and databases intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions.
This Website is protected by the laws on copyright and by the relevant international conventions. It is strictly forbidden to make copies, whether partial or total and on whichever media without prior approval.
The AGENT™ Drug-Coated Balloon (DCB) optimises drug transfer to the target vessel’s tissue through its TransPax coating, a proprietary formulation of Paclitaxel (PTx) and a citrate ester excipient. With drug transfer optimized1, go into the case with confidence that your patients will receive the best care possible.
TransPaxTM coating ensures targeted delivery of Paclitaxel2.
Optimal dose of 2 µg/mm2 compared to 3 µg/mm2 of market leading DCBs3.
By optimising the choice of excipient and the formulation, AGENT is able to achieve similar long term Paclitaxel levels with a 50% reduction in Paclitaxel loading compared to majority of DCB competitors on the market2.
Pharmacokinetic tissue level comparable to Taxus Stent over time2.
The Paclitaxel in TransPax coating is in crystalline form. This morphology has lower solubility than an amorphous form which allows the drug to be better absorbed by the vessel as the crystalline particles act as sustained reservoirs that lead to better tissue absorption4.